Strahlentherapie 1996
DOI: 10.1007/978-3-642-79432-2_4
|View full text |Cite
|
Sign up to set email alerts
|

Biologische Grundlagen der Strahlentherapie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

1997
1997
2006
2006

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 173 publications
0
1
0
1
Order By: Relevance
“…It is known that dividing cells are more radiosensitive than quiescent cells. Especially during mitosis, G2-phase and early S-phase, cells are very vulnerable [30]. Cell loss can be compensated by repopulation, if overall treat- Figure 3.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is known that dividing cells are more radiosensitive than quiescent cells. Especially during mitosis, G2-phase and early S-phase, cells are very vulnerable [30]. Cell loss can be compensated by repopulation, if overall treat- Figure 3.…”
Section: Discussionmentioning
confidence: 99%
“…Höhere Rezidivraten vor der ICBT waren mit einer signifikant niedrigeren Wahrscheinlichkeit für ein Rezidiv nach ICBT verbunden. ment time is too long and/or applied dose of radiation or drug is low [30]. Therefore, the slow delivery of drug by DES might be disadvantageous in aggressively proliferating tissue when compared to the high dose intensity of local brachytherapy.…”
Section: Abbildung 3 Isr-freiheit Nach Pci + Icbt Von Patienten Mit unclassified